Protagenic Therapeutics, Inc. (PTIX) Price History & Returns
How Protagenic Therapeutics, Inc. (PTIX) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $0.26 sits 2% of the way up a 52-week range of $0.14 to $6.20; 95.8% below the 52-week high; below its 50-day moving average of $0.51; below its 200-day average of $1.19; a beta of 0.47 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
0 of 5 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 11 of 36 months closed higher than the month before. Each figure is the last close in that month.
Protagenic Therapeutics, Inc. (PTIX) price history — frequently asked questions
How has Protagenic Therapeutics, Inc. performed over the last year?
Protagenic Therapeutics, Inc. (PTIX) has fallen 92.7% over the last twelve months, measured on price alone.
What is Protagenic Therapeutics, Inc.'s five-year return?
Over five years the PTIX share price has lost 99.8%, excluding dividends.
What is Protagenic Therapeutics, Inc.'s 52-week range?
Over the last year Protagenic Therapeutics, Inc. (PTIX) has traded between $0.14 and $6.20.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.